35
Claris Biotherapeutics, Inc. files Form D
Company raise update · Raising · Offering $121.5M · Sold $55.7M · HALF MOON BAY, CA · filed 2026-08-12
40
Claris Biotherapeutics, Inc. raises $2.3M under Reg D
Company raise · Closed · JERSEY CITY, NJ · Form D filed 2025-09-22
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Meredith Fisher | Director |
| Reza Dana | Director |
| Kenneth Harrison | Director |
| Henry Rath | Executive Officer |
| Susan Orr | Executive Officer |
| Clarke Atwell | Executive Officer, Director |
| Marc de Garidel | Director |
Signed by Clarke Atwell, President & Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
55
Claris Biotherapeutics, Inc. raises $55.7M under Reg D
Company raise · Raising · Offering $121.5M · Sold $55.7M · HALF MOON BAY, CA · filed 2026-08-07
45
Claris Biotherapeutics, Inc. raises $3.3M under Reg D
Company raise · Raising · Offering $3.3M · Sold $3.3M · JERSEY CITY, NJ · filed 2025-03-07